Vertex Pharmaceuticals, Inc. (VRTX)
504.73
-2.01
(-0.40%)
USD |
NASDAQ |
Oct 02, 16:00
505.10
+0.37
(+0.07%)
After-Hours: 20:00
Vertex Pharmaceuticals Price : 504.73 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 509.50 | 509.50 | 499.95 | 504.73 | 939659.0 |
| Oct 01, 2026 | 522.39 | 523.52 | 505.27 | 506.74 | 1.195M |
| Sep 30, 2026 | 525.26 | 529.72 | 522.74 | 522.81 | 1.146M |
| Sep 29, 2026 | 522.22 | 529.46 | 519.24 | 526.73 | 688927.0 |
| Sep 28, 2026 | 524.27 | 529.89 | 521.16 | 527.67 | 824740.0 |
| Sep 25, 2026 | 522.55 | 527.69 | 518.92 | 526.19 | 756206.0 |
| Sep 24, 2026 | 515.56 | 528.99 | 515.30 | 522.38 | 941057.0 |
| Sep 23, 2026 | 515.60 | 525.43 | 509.56 | 516.34 | 1.214M |
| Sep 22, 2026 | 521.69 | 525.97 | 508.14 | 514.99 | 1.387M |
| Sep 21, 2026 | 506.85 | 514.10 | 501.01 | 510.72 | 906682.0 |
| Sep 18, 2026 | 516.34 | 518.10 | 505.01 | 508.34 | 2.435M |
| Sep 17, 2026 | 518.35 | 519.07 | 510.20 | 516.34 | 900050.0 |
| Sep 16, 2026 | 513.80 | 517.95 | 511.35 | 513.26 | 638512.0 |
| Sep 15, 2026 | 519.94 | 519.94 | 511.00 | 514.63 | 824891.0 |
| Sep 14, 2026 | 522.17 | 525.29 | 514.66 | 519.51 | 837109.0 |
| Sep 11, 2026 | 522.10 | 522.10 | 511.81 | 515.44 | 875636.0 |
| Sep 10, 2026 | 519.13 | 522.60 | 514.32 | 514.56 | 815172.0 |
| Sep 09, 2026 | 524.00 | 528.16 | 520.08 | 521.12 | 958511.0 |
| Sep 08, 2026 | 529.64 | 535.00 | 520.20 | 528.90 | 1.121M |
| Sep 04, 2026 | 549.50 | 556.99 | 544.48 | 546.12 | 803524.0 |
| Sep 03, 2026 | 559.00 | 560.25 | 551.61 | 557.96 | 800964.0 |
| Sep 02, 2026 | 552.42 | 558.36 | 549.07 | 556.75 | 1.735M |
| Sep 01, 2026 | 548.60 | 551.40 | 545.08 | 547.65 | 735119.0 |
| Aug 31, 2026 | 535.38 | 546.84 | 532.23 | 544.52 | 1.198M |
| Aug 28, 2026 | 547.09 | 549.57 | 540.08 | 541.69 | 886917.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Gilead Sciences, Inc. | 144.74 |
| Sionna Therapeutics, Inc. | 4.91 |
| Regeneron Pharmaceuticals, Inc. | 735.20 |
| Ionis Pharmaceuticals, Inc. | 43.54 |
Price Related Metrics
| PE Ratio | 29.36 |
| PS Ratio | 10.19 |
| PEG Ratio | 1.285 |
| Price to Book Value | 6.315 |
| Price to Free Cash Flow | 34.08 |
| Earnings Yield | 3.41% |
| Market Cap | 127.87B |
| PEGY Ratio | 1.285 |
| Operating PE Ratio | 25.76 |
| Normalized PE Ratio | 28.58 |